About Indiva (CVE:NDVA)

Indiva Limited engages in the production of medical grade cannabis products in Canada. It offers dried cannabis flowers, and medical cannabis oils and extracts; and sativas, indicas, hybrids, and high-CBD strains. The company is based in Ottawa, Canada.

Receive NDVA News and Ratings via Email

Sign-up to receive the latest news and ratings for NDVA and its competitors with MarketBeat's FREE daily newsletter.

Has Indiva been receiving favorable news coverage?

News articles about NDVA stock have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Indiva earned a media sentiment score of 0.04 on Accern's scale. They also assigned media headlines about the company an impact score of 45.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Indiva?

Shares of NDVA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Indiva's stock price today?

One share of NDVA stock can currently be purchased for approximately C$0.74.

How big of a company is Indiva?

Indiva has a market capitalization of C$51.87 million.

MarketBeat Community Rating for Indiva (NDVA)

MarketBeat's community ratings are surveys of what our community members think about Indiva and other stocks. Vote "Outperform" if you believe NDVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDVA will underperform the S&P 500 over the long term. You may vote once every thirty days.